These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

924 related items for PubMed ID: 8919160

  • 21. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Canick JA, Saller DN, Bowers GB.
    N Engl J Med; 1992 Aug 27; 327(9):588-93. PubMed ID: 1379344
    [Abstract] [Full Text] [Related]

  • 22. Maternal serum screening for birth defects: results of a Connecticut regional program.
    Benn PA, Horne D, Craffey A, Collins R, Ramsdell L, Greenstein R.
    Conn Med; 1996 Jun 27; 60(6):323-7. PubMed ID: 8706425
    [Abstract] [Full Text] [Related]

  • 23. [Trisomy-21 screening using AFPplus in the eastern part of Switzerland].
    Zimmermann R, Schmid W, Binkert F, Achermann J, Huch R, Huch A.
    Schweiz Med Wochenschr; 1995 Jul 01; 125(26):1286-93. PubMed ID: 7541552
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Prenatal serum screening for Down's syndrome].
    Müller U, Benz R, Krahner-Pilat M, Terinde R.
    Z Geburtshilfe Perinatol; 1992 Jul 01; 196(3):129-33. PubMed ID: 1379769
    [Abstract] [Full Text] [Related]

  • 29. Prenatal biochemical screening for Down's syndrome and neural tube defects.
    Wald NJ, Kennard A.
    Curr Opin Obstet Gynecol; 1992 Apr 01; 4(2):302-7. PubMed ID: 1373963
    [Abstract] [Full Text] [Related]

  • 30. Down's syndrome: current screening techniques.
    White RS.
    South Med J; 1989 Dec 01; 82(12):1483-6. PubMed ID: 2480649
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Cost-effectiveness analysis of triple test in second-trimester maternal serum screening for Down's syndrome: an experience from Taiwan with decreasing birth rate but increasing population of old pregnant women.
    Hwa HL, Yen MF, Lin CL, Ko TM, Hsieh FJ, Chen TH.
    J Eval Clin Pract; 2008 Apr 01; 14(2):191-7. PubMed ID: 18284525
    [Abstract] [Full Text] [Related]

  • 34. Multiple-marker screening for Down's syndrome: a method of assessing the statistical robustness of proposed tests.
    Morris JK, Bestwick J, Wald NJ.
    J Med Screen; 2008 Apr 01; 15(2):55-61. PubMed ID: 18573771
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne). The Brighton and Eastbourne Down's Syndrome Screening Group.
    Piggott M, Wilkinson P, Bennett J.
    J Med Screen; 1994 Jan 01; 1(1):45-9. PubMed ID: 8790485
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 47.